Amerigo Scientific has launched an extensive range of GMP-grade proteins designed specifically to facilitate the development and clinical implementation of cell therapies. This strategic move marks a significant step in transitioning from research-grade materials to GMP-compliant raw materials, which is crucial for advancing therapeutic candidates through late-stage clinical trials and into commercialization.
Comprehensive Protein Portfolio
The new protein product line from Amerigo Scientific includes GMP-grade cytokines and growth factors that are vital for cell therapy manufacturing. Each product is produced in compliance with stringent regulatory guidelines, ensuring consistency, safety, and traceable animal-free biological activity—essential components for meeting the regulatory requirements in cell and gene therapy processes.
Addressing Developmental Needs
According to Amerigo Scientific’s business development manager, the demand for cell therapy development necessitates high-quality, well-characterized reagents. The company’s GMP-grade proteins respond to this pressing need, equipping researchers and manufacturers with dependable tools to confidently progress their projects from preclinical research to clinical applications.
Key Cytokines for Immune Cell Therapy
The portfolio features critical cytokines used in immune cell therapies, including IFN-gamma, IL-2, IL-4, IL-6, IL-7, IL-10, IL-15, and TNF-alpha. Most of these proteins are produced in E. coli, with many having active Drug Master File (DMF) filings. This regulatory preparedness underscores their suitability for clinical applications, ensuring researchers have access to compliant materials.
Growth Factors for Regenerative Medicine
Amerigo’s offering also includes essential growth factors for regenerative medicine, such as Activin A, Betacellulin, EGF, FGF basic, Flt-3 Ligand, IGF-I, SCF/c-kit Ligand, Thrombopoietin, and VEGF. These growth factors are sourced from validated expression systems, including E. coli, CHO cells, and NS0 cells, with selected products also holding DMF filings. This diversity ensures a robust supply chain for researchers engaged in innovative therapeutic development.
Seamless Integration into Manufacturing
The design of Amerigo Scientific’s GMP-grade proteins allows for smooth integration into standard cell culture and manufacturing protocols. These proteins are tailored to support the expansion, activation, and differentiation of both immune cells and stem cells, which are pivotal processes in cell therapy production.
Expanding Capabilities for the Cell Therapy Community
With this launch, Amerigo Scientific is poised to enhance its support for the burgeoning cell therapy sector. The company is committed to providing end-to-end solutions that tackle the unique quality and regulatory challenges faced by developers of transformative cellular medicines.
Commitment to Customer Support
Amerigo Scientific prides itself on its exceptional customer service and technical support. The team comprises highly educated professionals, many holding advanced degrees in life sciences, ensuring that they understand and can address the specific needs and inquiries of clients effectively.
Conclusion
Amerigo Scientific’s introduction of GMP-grade proteins represents a significant advancement in the field of cell therapy. The careful alignment of high-quality products with regulatory requirements positions the company as a key player in the evolving landscape of cellular medicine. By offering reliable and compliant solutions, Amerigo empowers researchers and manufacturers to bring innovative therapies to market with confidence.
- Key Takeaways:
- Amerigo Scientific launches GMP-grade proteins for cell therapy.
- The portfolio includes essential cytokines and growth factors.
- Proteins are compliant with regulatory guidelines and suitable for clinical applications.
- Designed for seamless integration into existing manufacturing processes.
- Strong customer support from a knowledgeable team enhances service quality.
Read more → www.azcentral.com